85390 Fibrinolysins screening i & r
Also known as: fibrinolysin screen, plasmin activity
Screening and investigation (confirmation) assay for fibrinolysin (plasmin) activity in plasma using substrate methodology to detect primary hyperfibrinolysis.
Clinical Context
Screens for excessive fibrinolytic activity in amyloidosis, liver disease, or malignancy; detects plasmin-mediated fibrin degradation independent of thrombin generation.
RVU Breakdown
| Work RVU | 0.75 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.75 |
Est. Medicare Payment
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.